Clinical Trial Update: Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intrathecal transplantation of mesenchymal stem cells in amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED